Analyst Insights
21.26% percent quarterly performance for Arcutis Biotherapeutics Inc (ARQT) is not indicative of the underlying story
On Tuesday, Arcutis Biotherapeutics Inc (NASDAQ: ARQT) was -1.04% drop from the session before settling in for the closing price of $17.29. A 52-week range
